Are All Stroke Patients Eligible for Fast Alteplase Treatment? An Analysis of Unavoidable Delays

Academic Emergency Medicine - United States
doi 10.1111/acem.12914
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Safety of Intravenous Alteplase Within 4.5 Hours for Patients Awakening With Stroke Symptoms

PLoS ONE
Multidisciplinary
2018English

Patients With Psoriatic Arthritis Who Are Not Eligible for Randomised Controlled Trials for TNF Inhibitors Have Treatment Response and Drug Survival Similar to Those Who Are Eligible

RMD Open
RheumatologyAllergyImmunology
2019English

Are All Centers Able to Offer an Adequate Carcinological Treatment for Gastric Carcinoma?

International Clinical Pathology Journal
2018English

Agricultural Ethics and Multifunctionality Are Unavoidable

Plant Physiology
Plant ScienceGeneticsPhysiology
2003English

Impact of Carillon on COAPT Eligible/Non-Eligible Patients

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Magnetoreception: An Unavoidable Step for Plant Evolution?

Trends in Plant Science
Plant Science
2014English

Multimedia Psychoeducation for Patients With Cancer Who Are Eligible for Clinical Trials: A Randomized Clinical Trial

Cancer
Cancer ResearchOncology
2018English

Assessment of the Upper Respiratory Tract in Patients Eligible for Treatment With Transverse Maxillary Expansion

Forum Ortodontyczne
Orthodontics
2018English

Abstract TP399: Complications From IV Alteplase in Mild Stroke Patients in a Multi-State Health System

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy